Guidance: Tetanus: the green book, chapter 30

Public Health England

November 13
13:35 2019

Tetanus: the green book, chapter 30

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need aversion of this document in a more accessible format, please email tell us what format you need. It will help us if you say what assistive technology you use.


This edition includes updates on:

  • epidemiology of tetanus
  • management of tetanus prone wounds
  • correct dose of immunoglobulin for prevention of tetanus
  • use of immunoglobulins for the treatment of clinical tetanus

Tetanus is an acute disease caused by the action of tetanus toxin, released following infection by the bacterium Clostridium tetani.

In November 2018 revised guidance for healthcare professionals on the use of immunoglobulins for the treatment of clinical tetanus and the management of tetanus prone wounds was issued.

Chapter 30 update patches.

Published 20 March 2013
Last updated 13 November 2019 +show all updates
  1. Added the revised chapter to include updates on the epidemiology and management of wounds and immunoglobulins.
  2. Updated advice on management of exposure prone wounds and supplies of immunoglobulin.
  3. Added link to revised guidance for health professionals.
  4. Added link to interim guidance.
  5. Updated the Body text to include a link to National Archives (chapter update patches) and NHS Choices.
  6. First published.

Related Articles


  1. We don't have any comments for this article yet. Why not join in and start a discussion.

Write a Comment

Your name:
Your email:

Post my comment

Recent Comments

Follow Us on Twitter

Share This

Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: